Perceptive Advisors, a life sciences investment firm, led a $56m funding round in Bridge to Life, a global supplier of organ preservation solutions. "We are pleased and excited to partner with the world–class healthcare investment team at Perceptive. This financing will help accelerate the development of our multi–organ machine perfusion systems platform which will revolutionize the existing organ transplantation landscape," Stevan Schweighardt, Bridge to Life Chairman and CEO.